Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Myocardial Recovery
100%
Acute Myocarditis
100%
Cannabidiol
100%
ARCHER
100%
Cardiac Magnetic Resonance Imaging (cMRI)
66%
Immunosuppressive Therapy
33%
Heart Failure
33%
Phase II Study
33%
Randomized Placebo-controlled Trial
33%
Myocarditis
33%
Inflammation
16%
In Vivo Model
16%
Anti-inflammatory Properties
16%
Placebo
16%
Moderate to Severe
16%
Transplantation
16%
Left Ventricular Ejection Fraction
16%
Murine Model
16%
Endothelial Function
16%
Older Adults
16%
Rare Diseases
16%
Sudden Cardiac Death
16%
Neurological Diseases
16%
Follow-up Data
16%
Diagnostic Criteria
16%
Treatment Duration
16%
Promising Treatment
16%
Targeted Treatment
16%
Treatment Effect
16%
Extracellular Volume
16%
Standard-of-care Therapy
16%
Oral Treatment
16%
Troponin
16%
Inflammation Markers
16%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
16%
Tolerated Dose
16%
Autoimmune Myocarditis
16%
Global Longitudinal Strain
16%
Interim Data
16%
MRI Parameters
16%
Animal Models of Cardiovascular Disease
16%
Design Paper
16%
Alpha Risk
16%
Pharmacology, Toxicology and Pharmaceutical Science
Myocarditis
100%
Cannabidiol
100%
Placebo
33%
Inflammation
22%
Congestive Heart Failure
22%
Anti-Inflammatory Drug
11%
Cardiovascular Disease
11%
Sudden Cardiac Death
11%
Immunosuppressive Agent
11%
Rare Disease
11%
Neurologic Disease
11%
Troponin
11%